Published 1 September 2009, doi:10.1136/bmj.b3514
Cite this as: BMJ 2009;339:b3514

Letters

QRISK validation and evaluation

ASSIGN, QRISK, and validation

The first 150 words of the full text of this article appear below.

We challenge the recent QRISK validation and editorial concluding that QRISK is the cardiovascular risk score for the United Kingdom.1 2

ASSIGN, QRISK’s precursor, was launched in Scotland before QRISK appeared.3 Predicting that scores omitting social deprivation (socioeconomic status) as a risk factor could exacerbate social gradients in disease, we developed ASSIGN to include it. ASSIGN was adopted without external validation because it correlated highly with the gold standard Framingham score. Discriminating rather better, even after adjustment for self-testing bias, it removed Framingham’s social inequity.

Subsequent to ASSIGN’s launch, QRISK authors told us that they were developing their own score. Our offer of collaborative comparison was not accepted, and QRISK coefficients were kept secret after its launch. The initial partisan publication, however, did show that ASSIGN discriminated better than Framingham in the QRESEARCH database where QRISK originated.4

We have not seen how QRISK deals with social deprivation in analyses similar to . . . [Full text of this article]

Hugh Tunstall-Pedoe, professor emeritus and senior research fellow1, Mark Woodward, senior research fellow (and Mount Sinai School of Medicine, New York)1, Graham Watt, professor2

1 Cardiovascular Epidemiology Unit, Institute for Cardiovascular Research, Ninewells Hospital, University of Dundee, Dundee DD1 9SY, 2 General Practice and Primary Care, University of Glasgow

h.tunstallpedoe@dundee.ac.uk


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
Gary S Collins and Douglas G Altman
BMJ 2009 339: b2584. [Abstract] [Full Text] [PDF]

QRISK or Framingham for predicting cardiovascular risk?
Rod Jackson, Roger Marshall, Andrew Kerr, Tania Riddell, and Sue Wells
BMJ 2009 339: b2673. [Extract] [Full Text]

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
Julia Hippisley-Cox, Carol Coupland, Yana Vinogradova, John Robson, Margaret May, and Peter Brindle
BMJ 2007 335: 136. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Collins, G. S, Altman, D. G (2009). Authors' reply. BMJ 339: b3516-b3516 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ